Dr. Mary Rachel Faris, Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 1200 Old York Rd, Abington Cancer Care Specialists, Abington, PA 19001 Phone: 215-481-2400 Fax: 215-481-7438 |
Dr. Christian Joseph Fidler, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1200 Old York Rd, Suite 1 Widener, Abington, PA 19001 Phone: 215-481-2400 Fax: 215-481-7438 |
Dr. Melanie Nordlinger, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1200 Old York Road, Abington Cancer Care Specialists, Abington, PA 19001 Phone: 215-481-2400 Fax: 215-481-7438 |
Dr. Willard Guy Andrews Iii, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1200 Old York Rd, Abington Cancer Care Specialists, Abington, PA 19001 Phone: 215-481-2400 Fax: 215-481-7438 |
Pooja Suresh, Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1200 Old York Rd, Abington, PA 19001 Phone: 215-481-2400 Fax: 215-481-7438 |
News Archive
The human brain's biochemistry may be a stumbling block that has been preventing an effective cure for brain cancer.
If you're in the market for long term care insurance but hate to fill out applications and wait, wait, wait, a leading agency has an alternative for you. Dispense with the paper and the delay; complete an electronic application, with live hand-holding, and get an answer pronto. The agency is LTC Financial Partners LLC (LTCFP), one of the nation's most experienced long term care insurance agencies.
Women with dense breast tissue soon might be adding a new product to their skincare routine to help them fight breast cancer.
Researchers at the University of Colorado Anschutz Medical Campus have found multiple genetic variants within the FUT2 gene that makes some people especially susceptible to middle ear infections.
TxCell SA, a biotechnology company developing innovative, cost-effective, personalized T-cell immunotherapies using antigen specific regulatory T-cells (Ag-Tregs) for severe chronic inflammatory and autoimmune diseases, announces today the receipt of the latest milestone payment of EUR 1 million from the Ovasave collaboration option, development and license agreement from Trizell (Trizell Holding SA).
› Verified 8 days ago